Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Azithromycin Treatment for the Airway Microbiome in Asthma

Phase 2

Terminated

Conditions: Asthma Chronic

Interventions: Drug: Placebo
Drug: Azithromycin

First Posted Date: 2018-11-09

Last Posted Date: 2023-08-23

Lead Sponsor: University of Chicago

Target Recruit Count: 17

Registration Number: NCT03736629

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)

Phase 3

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Carfilzomib
Drug: Lenalidomide
Drug: Dexamethasone
Drug: Bortezomib

First Posted Date: 2018-11-05

Last Posted Date: 2024-08-15

Lead Sponsor: University of Chicago

Target Recruit Count: 250

Registration Number: NCT03729804

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: Magnetic Resonance Imaging (MRI)

First Posted Date: 2018-11-02

Last Posted Date: 2023-08-03

Lead Sponsor: University of Chicago

Target Recruit Count: 400

Registration Number: NCT03729115

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery

Not Applicable

Recruiting

Conditions: Surgery

Interventions: Procedure: Routine Elective Surgery- In patient or out patient elective surgery
Diagnostic Test: Blood test for genetic testing
Other: Drug-genetic Profile

First Posted Date: 2018-11-02

Last Posted Date: 2024-01-29

Lead Sponsor: University of Chicago

Target Recruit Count: 1900

Registration Number: NCT03729180

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Effect of Noninvasive Electrical Brain Stimulation on Memory at Different Times of Day in Younger and Older Adults

Not Applicable

Completed

Conditions: Effect of tDCS on Memory in Older and Younger Adults

Interventions: Device: Active tDCS
Device: Sham tDCS

First Posted Date: 2018-10-30

Last Posted Date: 2024-05-14

Lead Sponsor: University of Chicago

Target Recruit Count: 271

Registration Number: NCT03723850

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Managing Diabetes to Gain Opportunities for a More Active Life

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: My Diabetes Goal Survey and Optional Care Management

First Posted Date: 2018-10-02

Last Posted Date: 2023-02-21

Lead Sponsor: University of Chicago

Target Recruit Count: 110

Registration Number: NCT03692208

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

Phase 1

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Enzalutamide
Drug: Relacorilant

First Posted Date: 2018-09-18

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 35

Registration Number: NCT03674814

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

Completed

Conditions: Cavernous Angioma
Cavernoma
Cerebral Cavernous Malformation
CCM
Cerebral Cavernous Malformations 1
Cerebral Cavernous Malformations 3
Cerebral Cavernous Malformations 2

First Posted Date: 2018-08-29

Last Posted Date: 2024-06-27

Lead Sponsor: University of Chicago

Target Recruit Count: 123

Registration Number: NCT03652181

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Behavioral Chronotype: Impact on Sleep and Metabolism

Not Applicable

Active, not recruiting

Conditions: Cardiovascular Diseases
Type2 Diabetes Mellitus

Interventions: Behavioral: Extended Overnight Fast
Behavioral: Late Total Caloric Intake
Behavioral: Early Total Caloric Intake

First Posted Date: 2018-08-27

Last Posted Date: 2024-05-02

Lead Sponsor: University of Chicago

Target Recruit Count: 200

Registration Number: NCT03647306

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Study to Develop Head Stabilizer for Use During Brain Radiation Therapy

Not Applicable

Withdrawn

Conditions: Brain Cancer
Brain Diseases

Interventions: Device: Wiersma Head Stabilizer
Device: AlignRT system

First Posted Date: 2018-08-14

Last Posted Date: 2020-05-08

Lead Sponsor: University of Chicago

Registration Number: NCT03629964

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy